A report called “Global Healthcare post COVID: Who benefits?” was put together by teams of health-care analysts at Jefferies’ offices in the U.S., Europe, India, Japan and Australia, and provided to the firm’s clients May 11.Here are the five U.S.-traded stocks included on the analysts’ list of expected “losers” from trends during and after the coronavirus pandemic: For health-services companies, the analysts pointed to a trend that those with foresight may have identified before the terrible events of 2020: “Asset-heavy, inpatient-focused companies are likely to be at a disadvantage to leaner peers that are more focused on outpatients, diagnostic testing and using big data post-COVID.” Who wouldn’t want to stay out of a nursing home or a hospital?